Texas Capital Bancshares enters the final stretch before its July 23 earnings report with a notable split between what insiders are doing and what at least one analyst just decided to do.
The most striking development in recent weeks is the CEO's decision to reduce his stake materially. Robert Holmes sold roughly 98,600 shares across two transactions on June 5 and June 8, collecting just over $10 million at prices near $101. The Chief Legal Officer followed with a smaller $353,000 sale on June 9. Against those disposals, the CFO's token 44-share purchase on June 15 barely registers. Net insider activity over the past 90 days runs positive in share-count terms only because of routine director awards in April — the discretionary selling picture is clearly one-directional. That Holmes moved at prices below where the stock now trades ($103.26, up 1.9% on the week) adds a layer of irony, but the volume of the disposals is the more relevant signal for positioning purposes.
The Street is moving the other way, at least at the margin. Citigroup lifted its rating from Sell to Neutral on June 30, lifting its target from $96 to $105 — a meaningful shift from a firm that had been among the more skeptical voices on the name. JP Morgan followed the next morning with a target raise to $110, though it held its Underweight rating. Those two moves in 48 hours brought fresh attention to a stock that had been range-bound. The mean analyst price target now sits at roughly $109, about 5.5% above the current price — modest upside by historical standards, and the consensus tone remains cautious rather than enthusiastic. The bull case centres on mid-to-high single-digit revenue growth in 2026, an active investment banking pipeline, and ongoing capital return. Bears point to pressure on net interest margins, rising deposit costs, and credit conditions that could slow loan growth in a more challenging macro environment.
Short interest tells its own story, and it reinforces the caution. Bears added aggressively mid-week: SI climbed 14.4% over the past seven days to 7.6% of the free float, with the bulk of the increase arriving on June 24-25 when estimated short shares jumped by roughly 440,000 in two sessions. The ORTEX short score has tracked the move, rising from around 50 to 52.9 over the past two weeks. That said, the borrow market shows no meaningful pressure — availability is extraordinarily loose at roughly 2,692% of current short interest, meaning there are more than 41 million shares available to borrow against a short base of under 3.5 million. Cost to borrow is running at just 0.52%, its highest level in a month but still unambiguously cheap. The setup is one where shorts are adding but the infrastructure for a squeeze is entirely absent.
Options positioning reinforces the bullish lean in the near term. The put/call ratio has collapsed to 0.29, nearly 1.6 standard deviations below its 20-day average of 0.50. Through most of May and early June the PCR ran between 0.57 and 0.64; the sharp drop since mid-June reflects a meaningful rotation toward calls. That shift is consistent with the stock's gradual recovery from its April post-earnings decline of 3.3%, though the options market's enthusiasm looks more tactical than structural given the concurrent rise in short interest. The factor score on EPS surprise ranks in the 79th percentile, suggesting the company has a solid track record of beating estimates — a fact that both the options bulls and the short-side bears will be weighing as July 23 approaches.
Among close peers, WTFC and ONB both rose around 2% on the week, roughly in line with TCBI. EBC outperformed, gaining 6%, while BKU was the lone laggard, slipping 1.4%. TCBI's performance is squarely mid-pack — neither confirming nor contradicting a differentiated thesis ahead of earnings. The July 23 print therefore becomes the clearest near-term pivot: it will test whether the Citigroup upgrade, the rising short interest, and the call-heavy options positioning are each reading the fundamental setup correctly.
See the live data behind this article on ORTEX.
Open TCBI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
